Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacyclics (PCYC) -- Ignore unavailable to you. Want to Upgrade?

To: Doug Meetmer who wrote (409)	2/16/1999 4:37:00 PM
From: Biomaven	Respond to of 717

Doug, PCYC's price action has always been a mystery to me. Perhaps one clue is the close correlation with MRVT: techstocks.com If this is what is driving the stock, it's pretty misguided in my opinion. The key to PCYC is Gd-Tex (and maybe eventually the roto-rooter), not the Lu-Tex cancer or eye stuff, which is where MRVT is like PCYC. If there is any further weakness, I will stubbornly add to my position. I don't think there are any results due out any time soon, (except maybe some further prelimiary roto-rooter stuff), so I doubt that this is behind the weakness. Peter